You have 9 free searches left this month | for more free features.

City

Boston (1)

Columbus (1)

Miami Lakes (1)

Pittsburgh (1)

San Antonio (1)

Condition

Hepatic Impairment (1)

Multiple Myeloma (1)

Recurrent Multiple Myeloma (1)

Refractory Multiple Myeloma (1)

Relapsed and Refractory Multiple Myeloma (1)

Overall Status

Not yet recruiting (4)

Sign in for free

Phase

phase 1 (3)

phase 1/phase 2 (1)

Sponsor

Abdullah Khan (1)

Bristol-Myers Squibb (1)

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company (1)

Kathleen Dorritie (1)

Collaborator

Bristol-Myers Squibb (1)

Study Documents

Intervention Type

drug (4)

biological (1)

procedure (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

mezigdomide

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

Not yet recruiting

Relapsed and Refractory Multiple Myeloma

Mezigdomide
+2 more

Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center

Sep 15, 2023

Hepatic Impairment Trial in Miami Lakes, San Antonio (Mezigdomide)

Not yet recruiting

Hepatic Impairment

Mezigdomide

Miami Lakes, Florida
+1 more

Jan 23, 2023

Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

Not yet recruiting

Multiple Myeloma

BMS-986393
+3 more

Boston, Massachusetts
+1 more

Nov 2, 2023

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

Not yet recruiting

Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Biospecimen Collection
+9 more

Columbus, Ohio

Ohio State University Comprehensive Cancer Center

Aug 1, 2023